from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1480/-

LFCtreatmentdescriptionclass of inhibitor

-2.195

Amikacinug/mL Amikacintranslation

-2.603

Cap5-10ug/mL Capreomycintranslation

-2.965

Rox10-50 ug/mL Roxithromycintranslation

-0.803

SM2-5 ug/mL Streptomycintranslation

-3.394

Tet5-10 ug/mL Tetracyclinetranslation

0.042

Rif0.2-5ug/mL Rifampicintranscription

-0.199

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.263

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.002

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.498

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.256

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.826

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.212

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.035

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.693

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.500

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.504

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.790

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.500

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.122

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.900

KCN5-20 ug/mL Potassium cyaniderespiration

-0.157

NaN30.2-2 mM Sodium aziderespiration

-0.225

Nigericin50 uM Nigericinrespiration

-0.565

TRC10-150 ug/mL Triclosanrespiration

0.196

TRZ10-25 ug/mL Thioridazinerespiration

-0.959

Valinomycin0.5-10 uM Valinomycinrespiration

-0.534

ZnSO42 mM ZnSO4respiration

0.005

menadione6-10 ug/mL Menadionerespiration

0.692

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.080

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.351

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.288

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.148

NRP_1Non-replicating persistence stage 1dosRassociated

0.261

Amp0.2mg/mL AmpicillincellWall

-0.145

Cephalexin20-100 ug/mL CephalexincellWall

-0.232

Cerulenin0.32-5 ug/mL CerulenincellWall

0.579

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.132

EMB10-20 ug/mL EthambutolcellWall

-0.698

Eta12-40 ug/mL EthionamidecellWall

-0.437

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.209

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.275

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.695

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.242

BZA0.12 mg/mL BenzamidearomaticAmides

0.142

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.245

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.579

H2O24 mM hydrogen peroxideDNAdamaging

0.264

Levo10 ug/mL LevofloxacinDNAdamaging

0.573

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.211

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.337

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.301

UVUV-irradiationDNAdamaging

-0.507

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.318

Antimycin12.5-50 ug/mL Antimycin A?

0.229

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.400

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.868

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.731

PA8240.2-2 ug/mL PA-824?

0.835

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.912

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.181

Verapamil50 uM Verapamil?

-0.063

mercaptoethanol2 mM 2-Mercaptoethanol?

0.103

methoxatin10-20 ug/mL Methoxatin?